175 related articles for article (PubMed ID: 38745123)
41. Genetic control of the human brain proteome.
Robins C; Liu Y; Fan W; Duong DM; Meigs J; Harerimana NV; Gerasimov ES; Dammer EB; Cutler DJ; Beach TG; Reiman EM; De Jager PL; Bennett DA; Lah JJ; Wingo AP; Levey AI; Seyfried NT; Wingo TS
Am J Hum Genet; 2021 Mar; 108(3):400-410. PubMed ID: 33571421
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
Stanilova S; Stanilov N; Julianov A; Manolova I; Miteva L
PLoS One; 2018; 13(8):e0201775. PubMed ID: 30071009
[TBL] [Abstract][Full Text] [Related]
43. LncRNA HOXC-AS3 overexpression inhibits TGF-β2-induced colorectal cancer cell migration and invasion by sponging miR-1269.
Zhang TT; Chen HP; Yu SY; Zhao SP
Hum Exp Toxicol; 2022; 41():9603271221093630. PubMed ID: 35537198
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.
Montagut C; Argilés G; Ciardiello F; Poulsen TT; Dienstmann R; Kragh M; Kopetz S; Lindsted T; Ding C; Vidal J; Clausell-Tormos J; Siravegna G; Sánchez-Martín FJ; Koefoed K; Pedersen MW; Grandal MM; Dvorkin M; Wyrwicz L; Rovira A; Cubillo A; Salazar R; Desseigne F; Nadal C; Albanell J; Zagonel V; Siena S; Fumi G; Rospo G; Nadler P; Horak ID; Bardelli A; Tabernero J
JAMA Oncol; 2018 Apr; 4(4):e175245. PubMed ID: 29423521
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide identification of circulating-miRNA expression quantitative trait loci reveals the role of several miRNAs in the regulation of cardiometabolic phenotypes.
Nikpay M; Beehler K; Valsesia A; Hager J; Harper ME; Dent R; McPherson R
Cardiovasc Res; 2019 Sep; 115(11):1629-1645. PubMed ID: 30715214
[TBL] [Abstract][Full Text] [Related]
46. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
47. Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study.
Pham TT; Nimptsch K; Papadimitriou N; Aleksandrova K; Jenab M; Gunter MJ; Le Marchand L; Li L; Lynch BM; Castellví-Bel S; Phipps AI; Schmit SL; Brenner H; Ogino S; Giovannucci E; Pischon T
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14889-14900. PubMed ID: 37599317
[TBL] [Abstract][Full Text] [Related]
48. A fully joint Bayesian quantitative trait locus mapping of human protein abundance in plasma.
Ruffieux H; Carayol J; Popescu R; Harper ME; Dent R; Saris WHM; Astrup A; Hager J; Davison AC; Valsesia A
PLoS Comput Biol; 2020 Jun; 16(6):e1007882. PubMed ID: 32492067
[TBL] [Abstract][Full Text] [Related]
49. The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal Cancer.
Karpuz T; Araz M; Korkmaz L; Kılınc I; Findik S; Karaagaç M; Eryilmaz MK; Artac M
J Gastrointest Cancer; 2020 Jun; 51(2):491-497. PubMed ID: 31218581
[TBL] [Abstract][Full Text] [Related]
50. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract][Full Text] [Related]
51. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).
Yuan C; Sato K; Hollis BW; Zhang S; Niedzwiecki D; Ou FS; Chang IW; O'Neil BH; Innocenti F; Lenz HJ; Blanke CD; Goldberg RM; Venook AP; Mayer RJ; Fuchs CS; Meyerhardt JA; Ng K
Clin Cancer Res; 2019 Dec; 25(24):7497-7505. PubMed ID: 31548349
[TBL] [Abstract][Full Text] [Related]
52. Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival.
Labadie JD; Savas S; Harrison TA; Banbury B; Huang Y; Buchanan DD; Campbell PT; Gallinger SJ; Giles GG; Gunter MJ; Hoffmeister M; Hsu L; Jenkins MA; Lin Y; Ogino S; Phipps AI; Slattery ML; Steinfelder RS; Sun W; Van Guelpen B; Hua X; Figuieredo JC; Pai RK; Nassir R; Qi L; Chan AT; Peters U; Newcomb PA
Sci Rep; 2022 Jan; 12(1):127. PubMed ID: 34996992
[TBL] [Abstract][Full Text] [Related]
53. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.
Wang M; Zhang Z; Pan D; Xin Z; Bu F; Zhang Y; Tian Q; Feng X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212174
[TBL] [Abstract][Full Text] [Related]
54. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer.
Tie J; Kinde I; Wang Y; Wong HL; Roebert J; Christie M; Tacey M; Wong R; Singh M; Karapetis CS; Desai J; Tran B; Strausberg RL; Diaz LA; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
Ann Oncol; 2015 Aug; 26(8):1715-22. PubMed ID: 25851626
[TBL] [Abstract][Full Text] [Related]
55. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer.
Wang L; Duan W; Yan S; Xie Y; Wang C
Biomed Pharmacother; 2019 May; 113():108758. PubMed ID: 30877883
[TBL] [Abstract][Full Text] [Related]
56. REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.
Nakajima H; Kotani D; Bando H; Kato T; Oki E; Shinozaki E; Sunakawa Y; Yamazaki K; Yuki S; Nakamura Y; Yamanaka T; Yoshino T; Ohta T; Taniguchi H; Kagawa Y
BMC Cancer; 2021 Jun; 21(1):674. PubMed ID: 34098908
[TBL] [Abstract][Full Text] [Related]
57. Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes.
Caron B; Patin E; Rotival M; Charbit B; Albert ML; Quintana-Murci L; Duffy D; Rausell A;
Genome Med; 2022 Mar; 14(1):28. PubMed ID: 35264221
[TBL] [Abstract][Full Text] [Related]
58. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A
Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958
[TBL] [Abstract][Full Text] [Related]
59. Deciphering mechanisms underlying the genetic variation of general production and liver quality traits in the overfed mule duck by pQTL analyses.
François Y; Vignal A; Molette C; Marty-Gasset N; Davail S; Liaubet L; Marie-Etancelin C
Genet Sel Evol; 2017 Apr; 49(1):38. PubMed ID: 28424047
[TBL] [Abstract][Full Text] [Related]
60. Identification of 969 protein quantitative trait loci in an African American population with kidney disease attributed to hypertension.
Surapaneni A; Schlosser P; Zhou L; Liu C; Chatterjee N; Arking DE; Dutta D; Coresh J; Rhee EP; Grams ME
Kidney Int; 2022 Nov; 102(5):1167-1177. PubMed ID: 35870639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
